Genetic News and Research

RSS

Mitochondrial genetics shed light on ALS Risk and protection

Using sequencing techniques, researchers associated 51 mutations in mitochondrial DNA with amyotrophic lateral sclerosis (ALS), an incurable degenerative neurological disorder that leads to muscle atrophy and paralysis.

31 Oct 2024

1950’s sugar rationing policies reduced risks of hypertension and diabetes

The study links early-life sugar exposure to chronic disease risk, suggesting that sugar restriction could enhance health and reduce diabetes and hypertension.

31 Oct 2024

New insights on the association between genes, gut microbiota, and mental health

The study identifies links between gut microbiota, genetic variants in IBD, and mental health disorders, offering insights into potential biomarkers for CMDs.

31 Oct 2024

Mapping tumor microenvironments: Uncovering spatial subclones for improved cancer treatment

Researchers investigate the spatial organization of cancer cells and the tumor microenvironment.

31 Oct 2024

AI shows promise for predicting embryonic health without invasive testing

Researchers evaluate the effectiveness of artificial intelligence algorithms in non-invasively predicting embryonic ploidy from embryonic images.

30 Oct 2024

For kids and teens, extra weight could mean a higher chance of long COVID

The study reveals a dose-response relationship between BMI and PASC risk in children, highlighting obesity as a key factor in post-COVID health challenges.

30 Oct 2024

Researchers identify genetic markers linked to neuropathic pain

European researchers have mapped the most comprehensive phenotyping of neuropathic pain and identified genetic markers associated with this serious condition.

30 Oct 2024

Fabric Genomics partners with Intermountain Children’s Health to enhance precision diagnosis of infants and children using whole genome sequencing from Broad Clinical Labs

Fabric Genomics, the leader in artificial intelligence (AI)-powered next generation sequencing interpretation, is announcing a new partnership with Intermountain Children’s Health to analyze the whole genomes of children sequenced by the Broad Clinical Labs to help speed diagnosis of kids who may have genetic diseases.

From Fabric Genomics 30 Oct 2024

descendantsDNA, Inc. engages Broad Clinical Labs and Fabric Genomics for genomic services to support human longevity

descendantsDNA, Inc. is pleased to announce a new agreement with Broad Clinical Labs (BCL) to advance human longevity through cutting-edge genomics.

From Fabric Genomics 30 Oct 2024

Survey reveals lack of awareness about pancreatic cancer risk among adults under age 50

While pancreatic cancer rates are rising in people under age 50, a new survey conducted by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) shows most people continue to believe that pancreatic disease affects only the elderly – and that there is nothing they can do to reduce their risk.

30 Oct 2024

Higher zinc intake linked to increased endometriosis risk, study finds

Researchers explore the association between zinc intake and endometriosis risk.

30 Oct 2024

Drug repurposing offers hope for SYNGAP1 patients

The SynGAP Research Fund 501(c)(3) has awarded a pair of grants to Dr. Clement Chow, a geneticist and Associate Professor in the Department of Human Genetics at the University of Utah. These grants are crucial steps in advancing therapeutic development for SYNGAP1-Related Disorders (SRD).

30 Oct 2024

Study questions causal link between cannabis and brain changes

Lifetime cannabis use is associated with several changes in brain structure and function in later life, suggests an observational study, but these associations may not be causal, finds a genetic analysis of the same data, published in the open access journal BMJ Mental Health.

30 Oct 2024

Researchers identify genetic markers for cardiovascular disease

A team of researchers from Girona Biomedical Research Institute Dr. Josep Trueta (IDIBGI), Bellvitge Biomedical Research Institute (IDIBELL), IRB Barcelona, Institut Català d'Oncologia (ICO), Germans Trias i Pujol Research Institute (IGTP) has worked together to identify possible genes associated with certain metabolites - molecules involved in the body's biochemical processes - and cardiovascular risk.

30 Oct 2024

Discovering how cells reorganize during division

A living cell is a bustling metropolis, with countless molecules and proteins navigating crowded spaces in every direction.

29 Oct 2024

Study identifies six cancer susceptibility genes

Identification of six cancer susceptibility genes offers new insights into genetic risk factors, potentially enhancing early detection and treatment strategies.

29 Oct 2024

Innovative method promises quick cancer diagnosis using ultrathin membranes

There are billions of tiny packets of cellular material called extracellular vesicles (EVs) that are produced by cells and released into each person's blood, saliva, and other bodily fluids.

29 Oct 2024

Study uncovers six cancer susceptibility genes

Scientists at deCODE genetics/Amgen, and their collaborators have discovered six novel genes with rare germline variants that associate with cancer risk. The findings are published today in Nature Genetics under the title "Gene-based burden tests of rare germline variants identify six cancer susceptibility genes".

29 Oct 2024

MGI and OncoDNA join forces to offer laboratories a streamlined NGS workflow for implementing Comprehensive Genomic Profiling (CGP) OncoDEEP® Kit in clinical practice

MGI (MGI Tech Co., Ltd. or its subsidiaries, together referred to MGI), a company committed to building core tools and technologies that drive innovation in life science, today announced the collaboration with OncoDNA, a genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases.

From MGI 29 Oct 2024

Could vitamin D be the missing link in managing type 2 diabetes? Recent study weighs in

Vitamin D's role in type 2 diabetes management is evolving, with evidence suggesting it may improve blood sugar levels and reduce diabetes-related inflammation.

29 Oct 2024